Achillion wins fast track status; Vernalis strikes discovery deal with Genentech; U.S./China JV wins grant;

 @FierceBiotech: Countering skeptics, Alnylam claims pioneering first in RNAi cholesterol study. Article | Follow @FierceBiotech

 @JohnCFierce: Biogen Idec strikes $299M deal for Isis antisense drug. Story | Follow @JohnCFierce

 @RyanMFierce: Quintiles has formed a new digital unit, using websites to tap patients for trials. News | Follow @RyanMFierce

> Achillion says its mid-stage hep C drug, ACH-1625, has won fast track status at the FDA. Story

> Vernalis has forged a drug discovery collaboration with Genentech, using its fragment and structure-based drug discovery platform against an undisclosed target. Vernalis release

> Australia's Phylogica has inked a discovery pact with J&J's Janssen, putting the biotech's Phylomer peptide platform to use in finding new drug classes. Phylogica release

> The upstart Ascletis, a U.S./China joint venture biotech company, has won a $1.6 million grant from Hangzhou National Hi-Tech Industrial Development Zone. Release

Pharma News

 @FiercePharma: The top 10 pharma layoffs of 2011. Report | Follow @FiercePharma

> Novartis idles plant, throwing off OTC drug supplies. News

> Which pharmas win the hedge-fund popularity contest? Story

Drug Delivery News

> India researchers pursue nanoparticle rabies treatment. Report

> New year brings new delay for SkyePharma's Flutiform asthma inhaler. Article

> ThromboGenics gears up marketing plans for eyeball injection drug. Story

> FDA issues new guidelines for transmucosal delivery of pain drug. News

> Veloxis, Athena ink deal for pill combining 2 heart disease drugs. Item

> Alnylam, Medtronic RNAi drug-device combo wows with preclinical data. Report

Biomarker News

> Biomarker could quickly diagnose heart attack. Story

> Breast cancer gene triggers mesothelioma response. Report

> When it comes to weight loss, watch the biomarkers and not the scale. Article

> CSF biomarkers could differentiate types of dementia. News

> Brain imaging could serve as Huntington's disease biomarker. Report

> Alzheimer's disease imaging signature predicts cognitive. Item

Medical Device News

> Corinthian raises $2M, sets sights on eye drug delivery device. Story

> Medtronic gets FDA OK for remote diabetes monitor. News

> Smith & Nephew to spin off biologics unit into JV. Article

> AirStrip scores regulatory win in EU. More

And Finally... Chinese officials sought to reassure the public after a bus driver died from bird flu, noting that the viral strain he died from could not spread from human to human. Story

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.